Tvardi Therapeutics

Tvardi Therapeutics

Tvardi Therapeutics

Tvardi is a clinical stage, private biotechnology company developing a new class of breakthrough medicines for diverse cancers.
Founded
2017
Raised
$14M
Follow us
Alexa global traffic share
Latest funding
$5,000,000
Grant - 2020
National Institutes of Health (NIH) V Foundation Cancer Prevention & Research Institute of Texas (CPRIT)
$9,000,000
Venture capital (Series A) - 2018
Team Size
1–10
Employees
$5,000,000 Grant
FinSMEs

Tvardi Therapeutics Receives $5M in Grant Funding

$9,000,000 Venture capital (Series A)
PE HUB

Tvardi Therapeutics lands $9 mln Series A